Lupin moves up on getting EIR from USFDA for Inhalation Research Center in Florida

30 Mar 2020 Evaluate
Lupin is currently trading at Rs. 560.00, up by 13.00 points or 2.38% from its previous closing of Rs. 547.00 on the BSE.

The scrip opened at Rs. 564.00 and has touched a high and low of Rs. 573.65 and Rs. 536.80 respectively. So far 45857 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 882.15 on 02-May-2019 and a 52 week low of Rs. 505.00 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 631.95 and Rs. 536.80 respectively. The current market cap of the company is Rs. 25716.70 crore.

The promoters holding in the company stood at 46.93%, while Institutions and Non-Institutions held 38.99% and 13.80% respectively.

Lupin has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Inhalation Research Center located at Coral Springs, Florida. The facility was inspected by the USFDA, between February 19, 2020 and February 26, 2020, on behalf of the U.K. MHRA for Lupin’s generic Fostair application to the U.K. MHRA.

Lupin’s Inhalation Research Center at Coral Springs, Florida, inaugurated in August 2015, focuses on research and development of respiratory products for the treatment of asthma, chronic obstructive pulmonary diseases and other respiratory ailments.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

1617.85 19.65 (1.23%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.